Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease

更正：一项随机、为期七天的研究，旨在评估使用新型 Co-Suspension™ 递送技术的格隆溴铵/富马酸福莫特罗固定剂量复方定量吸入器在中度至极重度慢性阻塞性肺疾病患者中的疗效和安全性。